ketanserin has been researched along with Diabetes Mellitus, Type 2 in 8 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine the efficacy of topically applied ketanserin for healing acceleration of diabetic foot ulcers." | 9.08 | Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. ( Castañeda, M; García-Alonso, J; Martínez-de Jesús, FR; Mendiola-Segura, I; Morales-Guzmán, M; Pérez-Morales, A, 1997) |
| "The objective of this study was to determine the efficacy of topically applied ketanserin for healing acceleration of diabetic foot ulcers." | 5.08 | Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. ( Castañeda, M; García-Alonso, J; Martínez-de Jesús, FR; Mendiola-Segura, I; Morales-Guzmán, M; Pérez-Morales, A, 1997) |
| "Ketanserin was well tolerated." | 2.66 | An evaluation of ketanserin therapy for the hypertensive diabetic patient. ( Tooke, JE; Williams, SA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pietraszek, MH | 2 |
| Takada, Y | 2 |
| Taminato, A | 2 |
| Yoshimi, T | 2 |
| Watanabe, I | 2 |
| Takada, A | 2 |
| Takeshita, N | 1 |
| Yamaguchi, I | 1 |
| Martínez-de Jesús, FR | 1 |
| Morales-Guzmán, M | 1 |
| Castañeda, M | 1 |
| Pérez-Morales, A | 1 |
| García-Alonso, J | 1 |
| Mendiola-Segura, I | 1 |
| Fujita, M | 1 |
| Carleo, R | 1 |
| Gobbo, M | 1 |
| Bonavita, M | 1 |
| De Matteo, A | 1 |
| Gallo, M | 1 |
| Gatti, A | 1 |
| Fogari, R | 1 |
| Zoppi, A | 1 |
| Pasotti, C | 1 |
| Nicrosini, S | 1 |
| Lazzari, P | 1 |
| Corradi, L | 1 |
| Tooke, JE | 1 |
| Williams, SA | 1 |
| Janka, HU | 1 |
| Mehnert, H | 1 |
| Fisher, R | 1 |
| Seiler, KU | 1 |
2 trials available for ketanserin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
Topics: Administration, Topical; Aged; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Di | 1997 |
An evaluation of ketanserin therapy for the hypertensive diabetic patient.
Topics: Blood Flow Velocity; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Double-Bl | 1989 |
6 other studies available for ketanserin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The effect of MCI-9042 on serotonin-induced platelet aggregation in type 2 diabetes mellitus.
Topics: Adult; Aged; Collagen; Diabetes Mellitus, Type 2; Female; Humans; Ketanserin; Male; Middle Aged; Pla | 1993 |
Meta-chlorophenylpiperazine attenuates formalin-induced nociceptive responses through 5-HT1/2 receptors in both normal and diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Formaldehyde; Indoles; Ketanser | 1995 |
Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Adult; Aged; Binding Sites; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabe | 1992 |
[Effects of ketanserin on glucose metabolism in hypertensive diabetic subjects].
Topics: Diabetes Mellitus, Type 2; Electrolytes; Female; Glucose; Hemodynamics; Humans; Hypertension; Insuli | 1990 |
Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitus.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glucose; Glucose Tol | 1990 |
Influence of ketanserin on glucose and lipid metabolism in diabetic patients with hypertension.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Ketanserin; Lipids; M | 1988 |